Timing of postmenopausal estrogen for optimal bone mineral density; The Rancho Bernardo study

JAMA

Volumn 277, Issue 7, 1997, Pages 543-547

  Schneider, Diane L ^a   Barrett Connor, Elizabeth L ^b   Morton, Deborah J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; UNITED STATES;

EID: 0031052861     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.7.543     Document Type: Article

References (36)

1. Lindsay R,Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976;1:1038-1041.
2. Aitken JM, Hart DM, Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. BMJ. 1973;3:315-518.
3. Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal oestrogens protect against fractures of hip and distal radius: a case-control study. Lancet. 1979;2:705-709.
4. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980;2:1151-1154.
5. Weiss NS, Ure CL, Ballard JH, Williams AR, Doling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980;303:1195-1198.
6. Kreiger N, Kelsey JL, Holford TR, O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol. 1982;116:141-148.
7. Richelson LS, Wahner HW, Melton LJ III, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984;311:1273-1275.
8. Brody JA, Farmer ME, White LR. Absence of menopausal effect on hip fracture occurrence in white females. Am J Public Health. 1984;74:1397-1398.
9. Christiansen C, Christensen MS, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 1981;1:459-461.
10. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-1146.
11. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med. 1993;329:1192-1193.
12. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
13. SAS/STAT User's Guide. 4th ed. Cary, NC: SAS Institute Inc; 1990;2.
14. Ettinger B. Postmenopausal osteoporosis. In: Bardin CW, ed. Current Therapy in Endocrinology and Metabolism. 5th ed. St Louis, Mo: Mosby-Year Book Inc; 1994:596-600.
15. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319-324.
16. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995;122:9-16.
17. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone. 1989;10:313-320.
18. Christiansen C, Riis BJ. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab. 1990;71:836-841.
19. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990;76:290-295.
20. Birkenhager JC, Erdtsieck RJ, Zeelenberg J, et al. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis? Bone Miner. 1992;18:251-265.
21. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausaI osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117: 1-9.
22. Marx CW, Dailey GE III, Cheney C, Vint VC III, Muchmore DB. Do estrogens improve bone mineral density in osteoporotic women over age 65? J Bone Miner Res. 1992;7:1275-1279.
23. Szejnfeld VL, Souen JS, Baracat EC, Atra E, de Lima GR. Do estrogens improve bone mass in osteoporotic women over ten years of menopause? Sao Paulo Med J. 1994;112:517-520.
24. Grey AB, Cundy TF, Reid IR. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis. Clin Endocrinol. 1994;40:671 -677.
25. Kohrt WM, Birge SJ. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women. Osteoporosis Int. 1995;5:150-155.
26. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy, I: a 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol. 1979;53:277-281.
27. Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol. 1987;156:1516-1523.
28. Heaney RP. Estrogen-calcium interactions in the postmenopause: a quantitative description. Bone Miner. 1990;11:67-84.
29. Ettinger B, Grady D. Maximizing the benefit of estrogen therapy for prevention of osteoporosis. Menopause. 1994;1:19-24.
30. Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab. 1995;80:2709-2714.
31. Lindsay R, Hart DM, MacLean A, Clark AC, Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet. 1978;1: 1325-1327.
32. Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen therapy. Osteoporosis Int. 1995;5:23-29.
33. Kiel DP, Felson DT, Andersen JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med. 1987;317:1169-1174.
34. Erdtsieck RJ, Pols HAP, Van Kuijk C, et al. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res. 1994;9: 277-283.
35. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol. 1984;63:759-763.
36. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987;106:40-45.